HMG-CoA reductase inhibitors (‘statins’) are ubiquitously used in prevention and treatment of cardiovascular disease, but are also known to have immunomodulatory, anti‐inflammatory and anti‐oxidative properties. The gene discussed is HMGCR; the disease is cardiovascular disorder.